Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
about
Belimumab in systemic lupus erythematosus: a perspective reviewEltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.Longitudinal validation of the Brief Index of Lupus Damage.Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000sFrequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentaryThe Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus.Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.Utilizing registries in systemic lupus erythematosus clinical research.Damage assessment in ANCA-associated vasculitis.Minimising steroids in lupus nephritis--will B cell depletion pave the way?Systemic lupus erythematosus: a therapeutic challenge for the XXI century.The complement system in systemic lupus erythematosus: an update.Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight.Optimizing the use of existing therapies in lupus.The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus.Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey.Clinical and financial burden of active lupus in Greece: a nationwide study.Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus.A study of the influence of ethnicity on serology and clinical features in lupus.The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.[Early lupus erythematosus].A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study.Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus.Disease evolution in late-onset and early-onset systemic lupus erythematosus.Predictors of maternal and fetal complications in SLE patients: a prospective study.Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus.Damage in lupus patients--what have we learned so far?
P2860
Q26796486-87FA409C-69F2-4AB6-B750-6A4DEF5C89D2Q33418800-05907A40-FFEE-45EB-AF69-5CE59DE446AEQ33801123-2F1C7ED1-B5EC-4BA4-9C84-7A3AD9034B91Q34739465-89B5E5FB-9B4C-438C-9D24-1625567BD894Q36188027-74F470D1-B824-4A78-A40E-BA9F0B28DC6AQ36315477-77D091A4-5A00-4F84-B070-044DF0044BB6Q37133875-AB8E719B-AD10-4DCB-B7F8-9173D885EB93Q37228138-9E6842DC-3A56-4E7C-8E80-428909E48F54Q37402771-B4F5E121-1A0F-4E7D-B133-A0021BF47035Q37456307-85E7B0B2-F2A4-4A01-A74F-CA026365CD24Q38011226-176ADA42-16E1-4109-A45C-F89BE436C1E3Q38043946-8547A3BB-F7EE-41A9-92D1-EF98F35DDC5AQ38095864-F13FDAED-5015-4230-A289-4C724BAF82E5Q38191835-30A0E215-CBF6-4256-8AF4-BBBF68DC0E03Q38213193-68086F2D-1627-4434-AA4D-98719F9179A1Q38388428-1F074B78-BEE7-44C5-98F1-9CC98037490FQ38425824-0430EC60-7185-4B2D-B7C0-213C21453E24Q38784456-094E5AF2-38C5-425D-959A-A06A0496605EQ38788410-964B51F0-B15D-4485-A9B6-55F5D04F65EDQ38800989-AD5D41FF-A685-4EF9-95A6-81AF9A8CC8D4Q38806513-DE526689-EC87-46C7-BD75-95FF8FF075D9Q38833876-81C343EB-D171-4A4B-8218-E82C51432856Q38842399-53A2F804-135B-41B7-B93B-385FAE8B85DBQ40309561-5BA0493D-323F-4A02-A8AA-2E91A2D04285Q40468255-936DFFA9-AD95-44EB-8DBB-D0849010E3D4Q40795030-1CAEC52B-25E6-4646-A078-41A04F21617EQ40933863-B7EBBF80-B6A2-452E-922A-79FA6E5B7430Q44476349-B1ED47AE-C19B-4D28-A878-9CFD3A51B8ABQ44615394-AAFF162E-D6C4-4B5E-A654-960C96A03CC1Q45081541-DB543691-47D0-45B6-B5B9-55D34F001130Q46055629-574DB934-8728-4C17-B112-13DDFBC439ABQ47147245-6127D579-C60E-4A64-8912-C57ACD21E21CQ47692440-7CC98126-29F8-4B58-A0DB-ABD52CF2F368Q47790266-EE8217A7-552C-4428-ADFA-70AC98829FC0Q47818914-B84CC76B-72E6-40AA-B30B-C1DAF4BD8FBCQ48182257-A60BF224-3666-4A90-B1F8-F890A3A41A7FQ53102157-54B7F65B-2E15-48D4-B3FB-5417467E68A7
P2860
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@en
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@nl
type
label
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@en
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@nl
prefLabel
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@en
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@nl
P2093
P2860
P50
P356
P1476
Evolution of disease burden ov ...... ic lupus erythematosus cohort.
@en
P2093
D J Wallace
G S Alarcón
G Sturfelt
P2860
P304
P356
10.1002/ACR.20648
P50
P577
2012-01-01T00:00:00Z